The 2025-2030 World Outlook for Veterinary Vaccines PDF covers the world outlook for veterinary vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.
In this report we define the sales of veterinary vaccines as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include APTIMMUNE Biologics, Bayer, Biogenesis Bago, Biogénesis Bagó, Bioniche Animal Health, Biovac, Boehringer Ingelheim, BRILLIANT BIO PHARMA Private, Ltd., CEVA, China Animal Husbandry, Diamond Animal Healthcare (Heska), Elanco, Eli Lilly and, Embrex, ENDOVAC Animal Health, Fort Dodge Animal Health, Heska, Hester, Hipra, Idt Biologika, ImmuCell, Imugene, Indian Immunological, Ltd., Intervet Inc. (Merck Animal Health), Jinyu Bio-Technology, Merck, Merial, NEOGEN Corporation, Phibro Animal Health, Tianjin Ringpu, TORIGEN, VEROVACCINES, Vetoquinol, Virbac, Zeotis, Inc., and Zoetis. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication’s release in 2024).
Table of Contents
Introduction
Overview of latent demand and P.I.E. (Potential Industry Expansion).
Methodology covering the steps for product definition, data collection, filtering, smoothing, estimation, aggregation, and latent demand allocation across cities.
Summary of Findings
Overview of the worldwide market potential.
Africa, Europe & The Middle East
Executive Summary for each region, followed by in-depth country analyses for various nations, including Algeria, Egypt, Nigeria, Russia, South Africa, and many more.
Asia
Executive Summary followed by detailed reports for countries like China, India, Japan, Malaysia, Thailand, and Vietnam.
Latin America
Executive Summary and country-specific insights for Argentina, Brazil, Chile, Mexico, and others.
North America & the Caribbean
Executive Summary and specific reports for countries like Canada, the United States, Cuba, and other Caribbean nations.
Oceania
Executive Summary with detailed insights for countries and territories like Australia, Fiji, New Zealand, and others.
Disclaimers, Warranties, and User Agreement Provisions
Legal disclaimers, safe harbor clauses, and provisions for user agreements.
